Harnessing the body’s immune system to fight off cancer, a tactic known as immunotherapy, has tremendously improved outcomes for patients. But a lingering problem with immunotherapy, as with many other cancer treatments, is relapse. In many cases the tumor comes back, and doctors don’t know why. Now, research from the lab of Elaine Fuchs, Rockefeller’s Rebecca C. Lancefield Professor, identifies the tumor cells responsible for thwarting the treatment and offers new insights into how they do it.
Read More
Health Rss 